Lumen is a biotechnology company focused on synthetic biology, protein design, and immunology to create a portfolio of biologic therapies and scientific discoveries.

Lumen Bioscience develops oral antibody therapeutics.

U.S. Department of Defense

U.S. Army Medical Research & Development Command

Medical Technology Enterprise Consortium

CARB-X

US Department of Energy

Avista Development

Bioeconomy Capital

WestRiver Group

Columbia Pacific Advisors

Lumen Bioscience

Brian Finrow discusses how the forever war against human #microbial pathogens desperately needs #innovation, but fresh thinking is needed to restore the R&D pipeline. #drugdevelopment

https://lnkd.in/ezHuy92R

We are pleased to announce $5.5 million in new funding from the U.S. Department of Defense, operating through the Medical CBRN Defense Consortium (MCDC), to develop enabling technologies for needle-free vaccines. This new technology could expand access and ease vaccine production, storage, and administration in future public health emergencies.

Read the announcement below,

https://lnkd.in/gEPvt65J

#needlefree #vaccine #seattle #wa #fundingnews #mcdc #biotech #publichealth #vaccinedevelopment

"The antibiotics crisis is a silent pandemic that threatens to knock modern society back into the medieval age of therapeutic leaches and serum therapy."

Check out Brian Finrow's (Lumen, CEO) new opinion piece in STAT on why scalable, preventive biologic drugs sidestep the market failure issues that block bedevil conventional antibiotics development.

Read below, 

#statnews #lumenbio #seattle #wa #biotech #biologics #biologicdrugs #antibiotics #article

https://lnkd.in/gMF3qVQ9

We are pleased to announce a $16.2 million award by the U.S. Department of Defense to advance LMN-201 through late-stage trials. LMN-201 is an investigational, orally delivered biologic drug to treat and prevent C. difficile infection (CDI).

Read the full release below, 

#cdiff #lumenbio #seattle #wa #clinicaltrial #biotech

https://lnkd.in/gyE_E6tN

BIO:LUMEN

Lumen

Analysis Not Available